Clariant AG · SIX:CLN
Clariant — FY2002 Earnings Presentation
52 slides from Clariant's earnings presentation, Feb 25, 2003
Slide 1: 2002 Year-End Results
2002 Year-End Results Basle, February 25, 2003 Analyst Conference Actions to be taken Results 2002: Improved operational performance Net loss due to goodwill amortization Slide 1
Slide 2: Key Achievements, Financial Results, Key Factors for 2003
2002 Year-End Results Actions to be taken Key Achievements Financial Results Results 2002: Key Factors for Clariant in 2003 Improved operational performance Net loss due to goodwill amortization Slide 2
Slide 3: Key Achievements (Dr. Reinhard Handte, CEO)
2002 Year-End Results Key Achievements Financial Results Key Factors for Clariant in 2003 Dr. Reinhard Handte Chief Executive Officer Slide 3
Slide 4: Key financial figures
2002 Year-End Results Actions to be taken Key Achievements Key financial figures Financial Results in m CHF 2002 2001 2001 Change in % compared reported pro forma* with pro forma Key Factors in 2003 CHF LC Sales 9330 9871 9652 -3.3 +4.7 Gross profit 3055 3084 2997 +1.9 +9.5 EBITDA 1112 1186 1139 -2.
Slide 5: LSE improvements less than expected
2002 Year-End Results Actions to be taken Key Achievements LSE improvements less than expected Financial Results Sales in m CHF EBITA in m CHF EBITDA in m CHF Key Factors in 2003 1st HY 2nd HY 1st HY 2nd HY 1st HY 2nd HY 2002 843 775 34 -2 102 44 Business trends Electronics Pharma CS SFC 2002 Outloo
Slide 6: Measures
2002 Year-End Results Actions to be taken Key Achievements Measures Financial Results Key Factors in 2003 Strengthen equity base - reduction of net debt Improving efficiency Increasing strategic flexibility Slide 6
Slide 7: Divisional-ROCE improved by 2%
2002 Year-End Results Actions to be taken Key Achievements Divisional-ROCE* improved by 2% Financial Results 25.0% Key Factors in 2003 Net debt in m CHF 20.0% 15.0% 10.0% 5.0% 0.0% -5.0% -10.0% TLP PA MB FUN LSE Total Slide 7 2001 2002 *pre tax & goodwill
Slide 8: Volumes and prices well under control
2002 Year-End Results Actions to be taken Key Achievements Volumes and prices well under control Financial Results Key Factors in 2003 Market performance n Sales in LC above previous year n Prices well under control n Operating margin improved Active portfolio management n Reduction of crude oil dep
Slide 9: Promising volume development
2002 Year-End Results Actions to be taken Key Achievements Promising volume development Financial Results Key Factors in 2003 2002 versus 2001 pro forma sales Volume Price Sales in LC Currency Sales in CHF -2.0% +6.7% +4.7% -8.0% -3.3% Slide 9
Slide 10: Segment Sales
2002 Year-End Results Actions to be taken Key Achievements Segment Sales Financial Results Sales in m CHF - Change in %- Key Factors in 2003 2002 2001* CHF LC Textile, Leather & 2769 2965 -6.6 +1.9 Paper Chemicals Pigments & Additives 1814 1872 -3.1 +4.5 Masterbatches 1027 1038 -1.1 +5.4 Functional
Slide 11: Segment EBITA
2002 Year-End Results Actions to be taken Key Achievements Segment EBITA Financial Results EBITA 2002 EBITA 2001* Key Factors in 2003 in m CHF margin margin Textile, Leather & 264 9.5% 8.2% Paper Chemicals Pigments & Additives 210 11.6% 12.3% Masterbatches 100 9.7% 7.8% Functional Chemicals 141 6.7%
Slide 12: Margins improved
2002 Year-End Results Actions to be taken Key Achievements Margins improved Financial Results Key Factors in 2003 9652 32.7% 9330 7.4% 31.1% 6.2% 2001 2002 2001 2002 2001 2002 Sales in m CHF* Gross Margin in %* EBITA Margin in %* * all 2001 figures are pro forma * Pro-forma Cost base reduction & res
Slide 13: CAPEX reduced
2002 Year-End Results Actions to be taken Key Achievements CAPEX reduced Financial Results Key Factors in 2003 535 505 425 5.1% 5.1% 339 4.6% 3.6% 1999 2000 2001 2002 Slide 13 in m CHF as % of sales
Slide 14: Net debt reduced far below CHF 4 bn
2002 Year-End Results Actions to be taken Key Achievements Net debt reduced far below CHF 4 bn Financial Results Key Factors in 2003 Net debt in m CHF 5999 - 45% 5329 5138 4282 4078 3457 3156 3476 2965 2779 Jun 98 Dec 98 Jun 99 Dec 99 Jun 00 Dec 00 Jun 01 Dec 01 Jun 02 Dec 02 in m CHF Net debt reduc
Slide 15: Financial Results (François Note, CFO)
2002 Year-End Results Key Achievements Financial Results Key Factors for Clariant in 2003 François Note Chief Financial Officer Slide 15
Slide 16: Development of financial profile
2002 Year-End Results Actions to be taken Key Achievements Development of financial profile Financial Results Key Factors in 2003 5138 4282 3340 3.6 3476 3156 3.1 3.1 2779 2.1 1.9 1.7 356 6 5.5 5 3.9 211 3.7 140 2.5 116 117 97 12/97 12/98 12/99 12/00 12/01 12/02 Slide 16 net debt in m CHF interest c
Slide 17: Change in equity
2002 Year-End Results Actions to be taken Key Achievements Change in equity Financial Results in m CHF Key Factors in 2003 1958 -890 +161 -268 +81 -46 -82 914 Impairment Disposals Recurring Currency Dividend Others net income Slide 17 Equity at 31 Dec. 01 Equity at 31 Dec. 02
Slide 18: Effects on our results
2002 Year-End Results Actions to be taken Key Achievements Effects on our results Financial Results in m CHF Key Factors in 2003 +81 -100 161 -790 -648 Net result Disposals Tangible Goodwill Net result recurring asset impairment writeoff Slide 18
Slide 19: EBITA analysis
2002 Year-End Results Actions to be taken Key Achievements EBITA analysis Financial Results in m CHF Key Factors in 2003 +103 -72 -83 +138 690 597 -197 +204 Pricing Raw Volume Synergies Currency Others** material EBITA* EBITA FY 2001 FY 2002 * EBITA pro forma Slide 19 ** Including significant provis
Slide 20: Solid contribution from operations
2002 Year-End Results Actions to be taken Key Achievements Solid contribution from operations Free cash flow / market cap. = 26% Financial Results Key Factors in 2003 in m CHF 2002 2001 Cash flow before changes in working capital 815 781 Cash flow from operating activities 751 796 Cash flow from inv
Slide 21: Pension plans
2002 Year-End Results Actions to be taken Key Achievements Pension plans Financial Results Funded plans Key Factors in 2003 n Pension obligations are a long-term debt, the average remaining working live of Clariant employees is over ten years n For 2003 no extra funding is necessary n For 2004 no su
Slide 22: Debt maturity profile
2002 Year-End Results Actions to be taken Key Achievements Debt maturity profile Financial Results Additional flexibility Financial debt 1 n Financing on a 2000 Key Factors in 2003 long-term basis Cash 1800 n Not utilized but 718 1600 available open long-term credit 1400 lines of 1200 CHF 1.3 bn n M
Slide 23: Key Factors for Clariant in 2003
2002 Year-End Results Key Achievements Financial Results Key Factors for Clariant in 2003 Dr. Reinhard Handte Chief Executive Officer Slide 23
Slide 24: Measures to be taken in 2003
2002 Year-End Results Actions to be taken Key Achievements Measures to be taken in 2003 Financial Results Key Factors in 2003 n Review of capital Strengthening structure equity base & n Sale of non core Reduction of net debt businesses of below CHF 2.5 bn approx. 7% of sales Slide 24
Slide 25: Measures to be taken in 2003
2002 Year-End Results Actions to be taken Key Achievements Measures to be taken in 2003 Financial Results Key Factors in 2003 n Fully owned legal entities for Electronic Materials, Pharma, Custom Synthesis and Masterbatches Increasing strategic n Less strategic importance flexibility of Life Science
Slide 26: Measures to be taken in 2003
2002 Year-End Results Actions to be taken Key Achievements Measures to be taken in 2003 Financial Results Key Factors in 2003 n Creation of regional service centers to reduce overhead costs n Significant reduction of capacity in Life Science unit Improve efficiency n Reduction of net current assets
Slide 27: Calendar of Corporate Events
2002 Year-End Results Actions to be taken Calendar of Corporate Events Quarterly reporting April 11, 2003 Annual General Meeting May 7, 2003 Results 1st quarter August 5, 2003 Results 2nd quarter November 4, 2003 Results 3rd quarter Slide 27
Slide 28: Disclaimer
2002 Year-End Results Actions to be taken Disclaimer This presentation contains certain statements that are neither reported financial results nor other historical information. This presentation also includes forward- looking statements. Because these forward-looking statements are subject to risks
Slide 29: Your Investor Relations contacts
2002 Year-End Results Actions to be taken Your Investor Relations contacts Iris M. Welten Karine Huttenschmitt Phone +41 61 469 67 47 Phone +41 61 469 67 48 Fax +41 61 469 67 67 Fax +41 61 469 67 67 Mobile +41 79 292 62 70 Mobile +41 79 456 63 48 iris.welten@clariant.com karine.huttenschmitt@ claria
Slide 30: Backup
2002 Year-End Results Backup Slide 30
Slide 31: Business structure as of January 1, 2003
2002 Year-End Results Actions to be taken Backup Business structure as of January 1, 2003 Textile, Pigments & Masterbatches Functional Life Science & Leather & Paper Additives Chemicals Electronic Chemicals Chemicals F. Dennefeld G. Hencken N. Gontha R. Meyer J. Mahler BU Coating Electronic Textile
Slide 32: Creating value for our shareholders and customers
2002 Year-End Results Actions to be taken Backup Creating value for our shareholders and customers Value Growth Efficiency Focussed diversification Basis for success: Motivated and educated people Slide 32
Slide 33: Creating value for our shareholders and customers
2002 Year-End Results Actions to be taken Backup Creating value for our shareholders and customers Growth Efficiency Focussed diversification Growth Strong market Cost reduction Portfolio positions management Efficiency Process Resource Focussed diversification Innovation optimization allocation and
Slide 34: Portfolio management: Divestiture of non-core businesses
2002 Year-End Results Actions to be taken Backup Portfolio management: Divestiture of non-core businesses Active portfolio management: Divestitures: n Concentrate on sustainable n 2001: Cassella-Offenbach to Allessa Chemie growth areas n Reduce raw material n 2001: dependency PVA / PVB business unit
Slide 35: Strong market positions
2002 Year-End Results Actions to be taken Backup Strong market positions No. 1 in 80% of Clariant businesses Categories Semi-specialties Specialties Fine chemicals Textile Electronic Textile Dyes Masterbatches Chemicals Materials Ink Pigments Process Paper BU Pharma Chemicals Detergents Custom Leath
Slide 36: Key for TLP in 2002: Differentiation through service
2002 Year-End Results Actions to be taken Backup Key for TLP in 2002: Differentiation through service for the customers Ongoing migration of textile business to low-cost countries n Following the markets results in continuous growth in China Increasing demand in paper markets n Strong growth and inc
Slide 37: Key for P&A in 2002: Implementation of new strategy
2002 Year-End Results Actions to be taken Backup Key for P&A in 2002: Implementation of new strategy Solid demand in paint & plastic industry despite economic downturn n Increasing market share and solid prices in Pigments lead to significant growth Packaging Challenging end user markets esp. in the
Slide 38: Key for MB in 2002: Strengthening leading position
2002 Year-End Results Actions to be taken Backup Key for MB in 2002: Strengthening leading position Positive development of the plastic industry overall n Strengthening leading position by stronger implementation of service as value added Automotive Textiles n Stronger key account approach n Good de
Slide 39: Key for FUN in 2002: Growth through service and innovation
2002 Year-End Results Actions to be taken Backup Key for FUN in 2002: Growth through service and innovation Gaining market share of liquid detergents vs. powder n Positive performance offset by provision for delay in start up of bleach activator plant Growing demand of end consumers for personal car
Slide 40: Key for LSE in 2002: Implementation of Life Science strategy
2002 Year-End Results Actions to be taken Backup Key for LSE in 2002: Implementation of Life Science strategy Turnaround on the market for electronics n Growth of Electronic Materials significantly above the market development Difficult trading condition in the whole pharmaceutical industry n Develo
Slide 41: Restructuring program 80% implemented
2002 Year-End Results Actions to be taken Backup Restructuring program 80% implemented cost saving reduced by CHF 50 m Cost base reduction in m CHF 200 Restructuring projects: n Projects total 100 80% implemented n Germany completed 60 FY 2001 FY 2002 FY 2003 Impacted by currency & shifted savings S
Slide 42: Sustainable contribution of restructuring
2002 Year-End Results Actions to be taken Backup Sustainable contribution of restructuring Number of employees Personnel costs 2'450 Net 31 debt in m CHF 546 2395 2'400 2'350 2346 2'300 28 904 2'250 2'200 27 849 2'150 2097 2'100 2000 2001 2002 2000 2001 2002 Slide 42
Slide 43: Germany: Good contribution to group financial result
2002 Year-End Results Actions to be taken Backup Germany: Good contribution to group financial result EBIT margin Personnel to sales 10% 25% n 100% program implemented è contributing 70% of group cost savings 5% n Higher margins è restructuring measures n Negative price impact on sales compensated b
Slide 44: Divisional sales in end user markets
2002 Year-End Results Actions to be taken Backup Divisional sales in end user markets Durables Automotive Paper 6% 5% Other 6% Agro 13% 7% Electronics 6% Healthcare 4% 21% Textiles 9% Packaging 13% 10% Non durable Construction Slide 44
Slide 45: Balanced sales and cost structure
2002 Year-End Results Actions to be taken Backup Balanced sales and cost structure Global sales distribution in % Global cost distribution in % JPY JPY Emerging 4.7 Emerging 3.9 markets markets 18.1 USD 15.7 USD 29.9 24.7 42.1 49.6 6.1 EUR EUR GBP 5.2 GBP Slide 45
Slide 46: Solid sales in local currencies
2002 Year-End Results Actions to be taken Backup Solid sales in local currencies BRL JPY Translation Translation Effect: -23.2% Effect: -10.5% 4.6% 4.7% Others USD Translation 20.9% 25.0% Translation effect: -13.3% effect: -7.6% 5.2% GBP EUR Translation Translation effect: -2.9% 39.7% effect: -3.9%
Slide 47: Tight asset management
2002 Year-End Results Actions to be taken Backup Tight asset management Accounts Receivable Inventory 1550 2000 1962 1515 1950 1500 1499 1900 1854 1850 1842 1450 1800 1403 1750 1400 1379 1689 1700 1350 1650 1600 1300 1550 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr Slide 47 in m
Slide 48: Raw material dependency reduced
2002 Year-End Results Actions to be taken Backup Raw material dependency reduced Percent of VAM1 of total raw material bill 2001 2002 2003 7% 4% 1% Sale of PVA / PVB business Sale of European emulsions unit to Kuraray and emulsion powders businesses to Celanese AG 1 Vinylacetate monomer Slide 48
Slide 49: Total obligations from pensions
2002 Year-End Results Actions to be taken Backup Total obligations from pensions -20 709 in m CHF Decrease +32 Unfunded Payment +144 plan to plan liabilities Increase 509 +44 252 Off B/S Off 43 Funded plan B/S Liabilities Assets DCO / other 157 141 DCO / other B/S B/S DBO 309 316 DBO B/S B/S 31 Dec
Slide 50: Interest expense substantially reduced by 31%
2002 Year-End Results Actions to be taken Backup Interest expense substantially reduced by 31% in m CHF 2002 2001 Financial expenses -229 -298 Currency impact -62 0.3 Total financial income and expenses -248 -246 Underlying interest rate sustained Slide 50
Slide 51: Segment EBITDA
2002 Year-End Results Actions to be taken Backup Segment EBITDA EBITDA 2002 EBITDA 2001* in m CHF margin margin Textile, Leather & 366 13.2% 12.2% Paper Chemicals Pigments & Additives 285 15.7% 15.8% Masterbatches 127 12.4% 10.2% Functional Chemicals 214 10.2% 10.8% Life Science & 146 9.0% 4.6% Elec
Slide 52: Strongly committed to Corporate Governance
2002 Year-End Results Actions to be taken Backup Strongly committed to Corporate Governance ü Separation of top functions § Split of CEO and Chairman role since 2002 ü Non-executive Board § All Board members non-executive directors, apart from CEO ü Adequate size and international composition of Boa